Acropolis Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026Acropolis Investment Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $18.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$18.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 20,428 | $5.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,145 | $3.0M |
| LLYELI LILLY & Co | 1,953 | $1.8M |
| MRKMerck & Co., Inc. | 14,643 | $1.8M |
| ABBVAbbVie Inc. | 6,988 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 20,462 | $1.2M |
| ABTABBOTT LABORATORIES | 8,024 | $824K |
| ELVElevance Health Inc. | 2,079 | $609K |
| AMGNAMGEN INC | 1,483 | $522K |
| PFEPFIZER INC | 18,379 | $516K |
| DGXQuest Diagnostics Incorporated | 2,476 | $485K |
| PMPhilip Morris International Inc | 2,108 | $349K |
| AUPHAurinia Pharmaceuticals Inc. | 19,657 | $291K |
| MCKMcKesson Corporation | 278 | $241K |
| GILDGILEAD SCIENCES, INC. | 1,582 | $220K |
| GEHCGE HealthCare Technologies Inc. | 1,818 | $129K |
| AZNASTRAZENECA PLC | 516 | $102K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.